# Phase 2 Adenocarcinoma Of Esophagus trials: 23 (2026)

ClinicalTrials.gov lists 23 trials in phase 2 for Adenocarcinoma Of Esophagus that are recruiting or not yet recruiting.

## The full list

Recruiting Phase 2 Adenocarcinoma Of Esophagus trials: 23 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-2/adenocarcinoma-of-esophagus

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 23
- Recruiting or not yet: 23
- Read on: November 19, 2026

## Trials

The 23 newest of 23, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| May 22, 2026 | NCT07603375 | Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Localized Esophageal Adenocarcinoma | Duke University | Phase 2 | Recruiting | Esophageal Adenocarcinoma | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07603375) |
| February 25, 2026 | NCT07432295 | Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2) | I-Mab Biopharma US Limited | Phase 2 | Recruiting | Solid Tumor, Advanced Cancer, Metastatic Cancer, Gastric Cancer, Gastroesophageal Junction Carcinoma, Esophageal... | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07432295) |
| December 15, 2025 | NCT07282912 | Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut... | Yale University | Phase 2 | Recruiting | Foregut Adenocarcinoma, Esophageal Adenocarcinoma, Gastroesophageal Adenocarcinoma, Gastric Adenocarcinoma, Pancreas... | 54 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07282912) |
| October 31, 2025 | NCT07223424 | Patient Preference for Subcutaneous vs. Intravenous Immune Therapy | Sponsor not shown (see the record) | Phase 2 | Recruiting | Renal Cell Carcinoma, Non Small Cell Lung Cancer, Melanoma, Colo-rectal Cancer (dMMR/MSI-H CRC), Hepatocellular... | 880 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07223424) |
| October 30, 2025 | NCT07222657 | Liquid Nitrogen Spray Cryotherapy Prior to Neoadjuvant Systemic Therapy in Esophageal Adenocarcinoma | Case Comprehensive Cancer Center | Phase 2 | Recruiting | Esophageal Adenocarcinoma, Esophageal Cancer | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07222657) |
| September 10, 2025 | NCT07164690 | Low-Dose Radiotherapy in Patients With Advanced Esophageal Squamous Cell Carcinoma Resistant to First-Line Chemotherapy Combined With... | Fudan University | Phase 2 | Not yet recruiting | Esophageal Adenocarcinoma, Radiotherapy | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07164690) |
| July 11, 2025 | NCT07059611 | Neoadjuvant Intra-tumoral RP2 and FLOT in Gastroesophageal Adenocarcinoma | Abramson Cancer Center at Penn Medicine | Phase 2 | Not yet recruiting | Gastric Adenocarcinoma, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07059611) |
| April 18, 2025 | NCT06933966 | Evaluation of Efficacy and Safety De-escalation Versus Standard Adjuvant Chemotherapy in Patients With Low Risk Localized Gastroesophageal... | Centre Leon Berard | Phase 2 | Not yet recruiting | Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma, Non Metastatic Disease | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06933966) |
| February 26, 2025 | NCT06846346 | Testing Ivonescimab in Combination With Chemotherapy in Advanced or Metastatic Gastric/Gastroesophageal Adenocarcinoma | UNICANCER | Phase 2 | Recruiting | Metastatic Esophageal Adenocarcinoma, Advanced Esophageal Adenocarcinoma, Metastatic Gastric Adenocarcinoma, Advanced... | 88 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06846346) |
| December 13, 2024 | NCT06732388 | Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus | National Cancer Institute (NCI) | Phase 2 | Recruiting | Barrett Esophagus, Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage IIA Esophageal Adenocarcinoma... | 76 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06732388) |
| November 14, 2024 | NCT06687876 | Metformin as a Metabolic Intervention in Oesophageal Adenocarcinomas to Improve Response to Neoadjuvant Chemoradiotherapy | Amsterdam UMC, location VUmc | Phase 2 | Recruiting | Oesophageal Adenocarcinoma, Tumor Microenvironment | 14 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06687876) |
| April 1, 2024 | NCT06340711 | Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma | Weill Medical College of Cornell University | Phase 2 | Recruiting | Esophageal Adenocarcinoma, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma | 27 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06340711) |
| December 8, 2023 | NCT06161818 | Total Neoadjuvant Therapy for Lymph Node-positive Adenocarcinoma of the OESophagus and Oesophagogastric Junction | Erasmus Medical Center | Phase 2 | Recruiting | Esophageal Cancer, Adenocarcinoma of the Esophagus | 216 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06161818) |
| September 21, 2023 | NCT06044311 | Oral TGF-beta Receptor I Inhibitor Vactosertib in SOC Chemoradiotherapy for Esophageal Adenocarcinoma | Sponsor not shown (see the record) | Phase 2 | Recruiting | Adenocarcinoma Esophagus, Locally Advanced Adenocarcinoma, Siewert Type I Adenocarcinoma of Esophagogastric Junction... | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06044311) |
| February 27, 2023 | NCT05745857 | Oral Bevacizumab-800CW and Cetuximab-800CW Administration to Detect Early Esophageal Adenocarcinomas | University Medical Center Groningen | Phase 2 | Recruiting | Barrett's Esophagus Without Dysplasia, Barrett Oesophagitis With Dysplasia, Esophageal Adenocarcinoma | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05745857) |
| December 15, 2022 | NCT05651594 | Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Locally Advanced or Metastatic... | Roswell Park Cancer Institute | Phase 2 | Recruiting | Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8, Clinical... | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05651594) |
| October 3, 2022 | NCT05563766 | A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer | VA Office of Research and Development | Phase 2 | Recruiting | Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Gastroesophageal Junction Carcinoma | 78 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05563766) |
| January 4, 2022 | NCT05177133 | Anti-PD-1 and CapOx for the First-line Treatment of dMMR Esophagogastric Cancer (AuspiCiOus) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Phase 2 | Recruiting | Gastric Adenocarcinoma, Esophageal Adenocarcinoma | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05177133) |
| June 25, 2021 | NCT04939051 | Obeticholic Acid for Prevention in Barrett's Esophagus | National Cancer Institute (NCI) | Phase 2 | Recruiting | Barrett Esophagus, Esophageal Adenocarcinoma | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04939051) |
| December 23, 2020 | NCT04682158 | Propranolol With Chemotherapy or Chemoradiation for Esophageal Adenocarcinoma | Roswell Park Cancer Institute | Phase 2 | Recruiting | Esophageal Adenocarcinoma | 106 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04682158) |
| November 5, 2019 | NCT04150640 | Oxaliplatin and Liposomal Irinotecan (Plus Trastuzumab for HER2-positive Disease) in Advanced Esophageal and Gastric Adenocarcinoma | University of Wisconsin, Madison | Phase 2 | Recruiting | Esophageal Adenocarcinoma, Gastric Adenocarcinoma | 52 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04150640) |
| October 3, 2019 | NCT04114136 | Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies | Sponsor not shown (see the record) | Phase 2 | Recruiting | Melanoma, NSCLC, Hepatocellular Carcinoma, Urothelial Cancer, Gastric Adenocarcinoma, HNSCC, Esophageal Adenocarcinoma... | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04114136) |
| May 19, 2017 | NCT03161522 | Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer | M.D. Anderson Cancer Center | Phase 2 | Recruiting | Gastric Adenocarcinoma, Oligometastasis, Stage IV Esophageal Adenocarcinoma AJCC v7, Stage IV Esophageal Cancer AJCC... | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03161522) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Roswell Park Cancer Institute | 2 |
| National Cancer Institute (NCI) | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Case Comprehensive Cancer Center | 1 |
| Duke University | 1 |
| Erasmus Medical Center | 1 |
| M.D. Anderson Cancer Center | 1 |
| Centre Leon Berard | 1 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Amsterdam UMC, location VUmc | 1 |
| Fudan University | 1 |
| I-Mab Biopharma US Limited | 1 |
| University of Wisconsin, Madison | 1 |
| UNICANCER | 1 |
| VA Office of Research and Development | 1 |
| Yale University | 1 |
| Weill Medical College of Cornell University | 1 |
| University Medical Center Groningen | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 16 |
| Netherlands | 4 |
| France | 2 |
| China | 1 |
| Japan | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Medical testing laboratories in the United States](https://specstream.ai/data/businesses/medical-testing-laboratories/united-states)
- [IT consultants in the United States](https://specstream.ai/data/businesses/it-consultants/united-states)
- [Hematology practices in the United States](https://specstream.ai/data/businesses/hematology-practices/united-states)
- [Fertility clinics in the United States](https://specstream.ai/data/businesses/fertility-clinics/united-states)
- [Drive thru bars in the United States](https://specstream.ai/data/businesses/drive-thru-bars/united-states)
- [Cocktail bars in the United States](https://specstream.ai/data/businesses/cocktail-bars/united-states)
